Nouvelle déclaration d'incident
No de la demande: 2014-0399
Numéro de référence du titulaire d'homologation: 2014CK023
Nom du titulaire (nom légal complet, aucune abbréviation): Bayer Inc
Adresse: 77 Belfield Rd
Ville: Toronto
État: ON
Pays: Canada
Code postal /Zip: M9W 1G6
Incident chez un animal domestique
Pays: UNITED STATES
État: UNKNOWN
Inconnu
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. Inconnu
Nom du produit: Advantage II (unknown)
Liquide
Oui
Unités: mL
Site: Animal / Usage sur un animal domestique
Non
Propriétaire de l'animal
Cat / Chat
domestic short hair
1
Femme
13
6
lbs
Cutanée
>1 wk <=1 mo / > 1 sem < = 1 mois
>8 hrs <=24 hrs / > 8 h < = 24 h
Système
>8 hrs <=24 hrs / > 8 h < = 24 h
Oui
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On an unspecified date, approximately 1 day post application, the cat began having seizures. The cat was seen by a veterinarian and unknown treatments were performed. On approximately 16 Oct 2013 the cat passed away. It is not known if a necropsy was performed. Update 2013-11-08: Immediately after product application the cat ran away. This behavior resolved within 10 minutes. An undetermined amount of time later the cat developed pruritus. Fleas were visible on the pet.The product was applied monthly (partial tube) from Nov 2012 thru Jan 2013 and the cat continued to have pruritus. On an unspecified date after the product was applied on 13 Feb 2013 the cat became blind. A cause for the vision loss was not determined. Continued partial tube product applications occurred from March 2013 thru 13 Sept 2013. The cat continued to have pruritus.On 06 Oct 2013 a partial tube of product was applied.On 16 Oct 2013 the seemed disoriented, anorexic and had one episode of vomiting.On 17 Oct 2013 the cat had a behavioral change going from episodes of hyperactivity to reluctancy to move. The cat then began paddling. Due to the clinical signs the cat was seen by the attending veterinarian. Unknown diagnostics and blood work were performed and revlealed the cat was hypokalemic. Unknown treatments were initiated and the cat began to improve on 18 Oct 2013; however later that day the cat began paddling again and shortly after passed away. No necropsy was performed. The attending veterinarian was suspicious this cat had an undiagnosed neoplasia.
Mort
Seizures and death are inconsistent with pharmacotoxicological product profile and experience and therefore not expected. Time to onset time with 10 days too long. Product has wide margin of safety. Oral LD50 in rat 642 mg/kg BW. 24-fold overdosage tolerated by cats without showing any side effect. Neither signs, nor time to onset nor chronology consistent with pharmaco-toxicological product proile. Previous exposure with no adverse reaction for already more than one year. The underlying cause of death of this cat was more likely due to an undiagnosed neoplasia according to case description as no necropsy was performed. Other medical problems also more likely in geriatric cat as indicated by hypokalemia which is probable cause for neurological signs. Based on the toxicological profile and inconsistent chronology a product relation is considered unlikely.